The effects of nutrients on the growth and quality of medicinal and aromatic plants, affecting athletic abilities

Renewed interest in medicinal and aromatic plants during the past 20 years has brought surging markets and production opportunities for these plant species. To enhance and maintain market growth, however, MAP production systems, whether cultivated or collected, will need to ensure sustainable production of quality plant materials that have been wholesomely grown and processed. The growing familiarity of western consumers with medicinal and aromatic plants places a premium on standardized plant materials that are organically produced and meet expectations for efficacy. Currently, market demand for MAP is nurtured by consumer demographics and by favorable impressions of bioactivity, but this demand remains susceptible to myths, traditions, and science reports associated with the plant materials. By addressing the problems of standardization and verifiable marker compounds along with issues such as plant domestication, conservation, biotechnology, and others that affect plant cultivation, producers and processors can assure acceptable products reach the marketplace and crop production opportunities will continue to grow. Introduction A recent resurgence of interest in medicinal plants in many Western nations, the continued dependence of people in much of the world on these species, and the advent of a globalized economy has brought sustainability challenges to the medicinal plant trade. The modern market for medicinal plants has, in general, grown over the past 15 years (Fig. 1), but remains fragile, subject to governmental regulations, research findings, and media publicity along with the usual factors associated with supply and demand. Indeed, many challenges to the continued growth of the market exist, including appropriate education of consumers, assurances of high quality products, and availability of a sustainable supply of plant material. The development of patentable, synthetic pharmaceuticals in the 1930s and 1940s in America and other Western countries (Table 1) resulted in the active abandonment of medicinal plants in health care, leaving new generations of both health care practitioners and the general populace with only a limited history, culture, and understanding about the appropriate use of medicinal species for preventing and treating human ailments (Craker and Gardner, 2003). Consumer confidence in pharmaceutical drug development, enhanced by the discovery of antibiotics and vaccinations that prevent or treat many diseases has lately decreased as drug costs escalate and major health problems, such as cancer, AIDS, cardiovascular disease, and numerous other problems continue to exist. An array of interests from medical professionals essentially committed to “modern” pharmaceuticals, consumers seeking alternative health care options, and herbalists promoting the use of medicinal and aromatic plants can convert challenges to market opportunities if growers and processors provide safe, useful plant products and educate consumers and health care professionals on benefits of medicinal plant products. Education of consumers and healthcare practitioners about the correct use of medicinal and aromatic plants and plant extracts will help ensure the continued recognition of the value of these products. For example, Western consumers accustomed Proc. WOCMAP III, Vol 2: Conservation Cultivation & Sustainable Use of MAPs Eds.: A. Jatisatienr, T. Paratasilpin, S. Elliott, V. Anusarnsunthorn, D. Wedge, L.E. Craker and Z.E. Gardner Acta Hort. 676, ISHS 2005 26 to taking a pharmaceutical drug and experiencing the effect of the drug within minutes to hours must learn that an herbal product that may take much longer to exhibit noticeable activity. Similarly, consumers and producers must replace the concept of taking drugs to treat pre-existing conditions with the concept of taking medicinal plants to improve general health and to treat both clinical and sub-clinical conditions. If consumers and health care providers are unfamiliar with the concepts of medicinal herb use, they cannot be expected to seek, recommend, or use these plants as medicine. Consumer Demographics As with any commodity, sales and use of medicinal plant products are influenced by the type of people that use these products. Indeed, a good share of the growth in sales of medicinal and aromatic plants and other natural products over the past 15 years can be attributed to the growth of certain demographic groups. Immigrants from Asia and Latin America have popularized a new palette of herbs and spices in restaurants and homes in the United States. This popularization has been such that U.S. spice consumption grew from 2 pounds per capita in 1976 to 3.2 pounds per capita in 1995 (Anonymous, 1998) (Fig. 2). Contributing to the increase in spice consumption is a change in lifestyle in many industrialized nations. The movement of women, historically the people responsible for meal preparation, from the home to workplace has altered traditional roles, requiring easier food preparation within the limited time available after work. In these instances, spices are frequently used to enhance the flavor of homemade and prepared meals. A highly significant trend among consumers is the increase in consumers interested in environmental issues, the so-called “green” consumers (Roper, 2002). Such consumers are willing to pay a premium for eco-friendly products, including organic foods, recycled products, and herbal remedies. These consumers value natural alternatives to conventional products including foods and medicines, thus medicinal plant products and natural food flavorings are favored by these consumers. Media Influences Media stories featuring medicinal plants appear highly influential in consumer demand and acceptance of medicinal plants. While medicinal plants were featured positively in several highly publicized stories in the late 1990s (Greenwald, 1998; Johnson et al., 1997), many of the more recent stories have been negative with concerns focused on several plant species (such as kava and ephedra) (Burros, 2002; Strugatch, 2002), with few headlines highlighting the benefits or proper use of medicinal plants. Most of the negative stories are concerned with the lack of standardization of dose or with reports of results from poorly designed research studies (Brody, 1999). Product Quality The popularization of medicinal plants in Western nations during the 1990s encouraged the formation of numerous new companies producing herbal medicines. Unfortunately, the quality of the plant materials (including differences due to natural variation, cultivation practices, and post harvest handling) and processing vary among companies, and thus the quality of oils and other extracts is highly variable. Surveys by independent laboratories have demonstrated significant variation in the quality and reported content of packaged herbal remedies (Anonymous, 2001; ConsumerLab, 2002). News reporting of such variation undoubtedly lowers consumer and health care provider confidence in medicinal plant products. Standardization of herbal products is the most commonly suggested solution for overcoming the natural variation of constituents in plant material. While standardization can help ensure product quality, recognized drawbacks to standardization exist. For example, in many plant species the active constituents of the species are not fully known. Secondly, a combination of plant constituents may be responsible for biological action of the plant or plant extract. Yet, if standard guidelines for marker compounds can be recognized and if plant selection, cultivation methodology, and processing can be

The concept of rural development, it stems from many factors and variables circumstantial of area as rural tourism, agritourism, products of territory, in our case the medicinal and aromatic plants. In this paper we estimate the land fund by purpose and destination of use is grouped into three categories, where the third, with about 53 thousand hectares, is less fertile, affected by erosion, and should be used with priority. Their expansion results to be 67% in mountain areas, 31% in hilly areas and only 2% in lowland areas. The more effective alternative according to our agriculture theory and practice is that of the aromatic and medicinal plants (medicinal and aromatic plants) that have multi-dimensional cultivating interests for our country, conditioned by the climatic and soil conditions as well as the economic and organizational conditions of a range of stakeholders related to the aromatic and medicinal plants, such as their growers, collectors, aggregators, processors and traders (exporters). In terms of our country the aromatic and medicinal plants have two main situations: From the wild, outdoor and, b) Cultivated, in increasingly growing areas, in different areas and with differentiated practices. Among the the aromatic and medicinal plants in complexity, sage, thyme and oregano have obvious superiority in area planted and the production realized out of their total. The advantage of the aromatic and medicinal plants results in full use of agricultural land, in a broader employment of free labor force (mainly women), increase of income, increase of their exports, which currently account for about 52-54 % of the total that agriculture as a whole realizes in the last years, etc.

Medicinal and aromatic plants are offered in a wide variety of products on the market. At least every fourth flowering plant is used. The enormous demand in botanicals results in a huge trade from local to international level. In the 1990s, the reported annual world-wide importation of pharmaceutical plants amounted on average to 400,000 t valued at USD 1,224 million. The international trade is dominated by only few countries. About 80 % of the world-wide imports and exports are allotted to only 12 countries with the dominance of temperate Asian and European countries. Whereas Japan and the Republic of Korea are the main consumers of pharmaceutical plants, and China and India are the world’s leading producing nations, Hong Kong, the USA and Germany stand out as important trade centres. Until now, the production of botanicals relies to a large degree on wildcollection. However, utilization and commerce of wild plant resources are not detrimental in themselves, but, for example, the increasing commercial collection, largely unmonitored trade, and habitat loss lead to an incomparably growing pressure on plant populations in the wild. World-wide an estimated 9,000 medicinal plant species are threatened. Conservation concepts and measures which have to meet future supply and the provisions of species conservation range from resource management, cultivation, shifting processing from consumer to source countries, species conservation to trade restrictions or even trade bans. Medicinal and aromatic plants are of high priority for conservation action, as wild-crafting will certainly continue to play a significant role in their future trade: the sustainable commercial use of their biological resources may provide a financial instrument for nature conservation. INTRODUCTION Phytopharmaceuticals, also some pharmaceuticals, herbal remedies, dietary supplements, homeopathics, medicinal and herbal teas, liqueurs, spirits, sweets, aromas and essences, perfumes, cosmetics, colouring agents, varnishes, fireworks, and detergents – plant-based products offered in a wide variety on the market. Whereas in some goods the herbal ingredients are evident, e.g. in teas or in herbal remedies where they are declared on the packaging, in other products the botanically source is more secret: the bitter taste of Campari is based on the Common Centaury (Centaurium erythraea), and the fenugreek (Trigonella foenum-graecum) contains steroid-saponins which are extracted for use in oral contraceptives. The use of botanical raw material is in many cases much cheaper than to use chemical alternative substances. As a consequence, there is an enormous demand in botanicals resulting in a huge trade, on local, regional, national and international level for domestic use and for commercial trade. Different aspects are associated with the trade in medicinal and aromatic plant material, the trade structure, trade volumes and values, the herbs used and their production, the ecological and socio-economic impacts of the trade, and the management of the botanical resources. Proc. XXVI IHC – Future for Medicinal and Aromatic Plants Eds. L.E. Craker et al. Acta Hort. 629, ISHS 2004 Publication supported by Can. Int. Dev. Agency (CIDA) 178 MEDICINAL AND AROMATIC PLANTS IN USE Species in Use World-wide, it is estimated that up to 70,000 species are used in folk medicine (Farnsworth and Soejarto, 1991). The WHO reports over 21,000 plant taxa used for medicinal purposes (Groombridge, 1992). Unfortunately, there is no idea how many species are used in the other areas of use, like cosmetics, spirits or aromas which makes determining exactly the number of all medicinal and aromatic plant species used worldwide impossible. However, it can be stated, that at least every fourth plant is in use, a calculation based upon the estimated total number of 300-350,000 flowering plants. The number of medicinal and aromatic plant species used in some regions are impressive: In India, which is said to have probably the oldest, richest and most diverse cultural traditions in the use of medicinal plants, about 7,500 species are used in ethnomedicines (Shankar and Majumdar, 1997) which is half of the country’s 17,000 Indian native plant species. In China, the total number of medicinal plants used in different parts of the country add up to some 6,000 species according to Xiao (1991) and to over ten thousand according to He and Sheng (1997). Of these, approximately 1,000 plant species are commonly used in Chinese medicine, and about half of these are considered as the main medicinal plants (He and Sheng, 1997). In Africa, over 5,000 plant species are known to be used for medicinal purposes (Iwu, 1993). In Europe with its long tradition in the use of botanicals, about 2,000 medicinal and aromatic plant species are used on a commercial basis (Lange, 1998). In Germany, Lange (1996) identified not less than 1,500 taxa as sources of medicinal and aromatic plant material. In Spain, it is estimated that 800 medicinal and aromatic plant species are used of which 450 species are associated with commercial use (Blanco and Breaux, 1997; Lange, 1998). Geographical Origin of the Species in Use Herbs used in a country can be either indigenous or native to other regions or even continents. The share of both plant groups depends on the country’s cultural preferences, importance of traditional medicines, history, trade relations, and of course of the wealth or poverty of a country. Traditional medicines are playing an important role in many parts of the world. In south and southeast Asia, the Ayurveda, Unani and Siddha medicines are widely distributed and based on not less than 400, 500 respective 1,800 native Indian plant species (Shankar and Majumdar, 1997). The TCM, the traditional medicine of eastern Asia, relies in most cases on indigenous plant species. Traditional healers in many African countries rely on local or at most regional plant material (Marshall, 1998). In Bulgaria, about 750 native plant species, or 20 % of the total flora, are used in folk medicine. Of these, 200300 species are most commonly used (Hardalova, 1997). Further, in Albania, 205 native plant species are used as sources of botanicals (Vaso, 1997; Lange, 1998). In Hungary, some 270 native medicinal and aromatic plant taxa are used, 180-200 of which are officially recognised by the Hungarian Pharmacopoeia (Bernath, 1996). Ozhatay et al. (1997) list a total of 337 native taxa that have been commercially traded in Turkey since at least 1990 (Lange, 2001). From the French pharmacopoeia and lists of medicines Goi et al. (1997; Lange, 1998) noted some 900 taxa, of which almost half are native to Europe. This means, that many countries rely on a major part on their own plant diversity. Many of them cannot afford to import foreign botanicals, finished herbal products or even phytopharmaceuticals and the country’s own “biodiversity” is mainly offered in a crude form or at most as little processed products on the market. On the other side, there are the developed countries which use besides indigenous plant species a lot of non-native species and process them in their well developed pharmaceutical, cosmetic and extract-producing industry. Accordingly, the plant material is offered to the consumers as mainly packed and finished products, and the crude material plays a minor role in the retail trade. This features apply above all to the highly

Bu çalışmada, Covid-19 (Kovid-19) pandemisine karşı sağlık çalışanları tarafından, geleneksel olarak kullanılan tıbbi ve aromatik bitkilerin değerlendirilmesi amaçlanmıştır. Araştırma tanımlayıcı modelde tasarlanmış olup 10 Temmuz-31 Aralık 2021 tarihleri arasında gerçekleştirilmiştir. Türkiye’deki sağlık çalışanları araştırma evrenini oluşturup basit rastgele örnekleme yöntemi kullanılmıştır. Verilerin toplanmasında, alan uzmanlarınca hazırlanan yarı yapılandırılmış anket formu kullanılmıştır. Demografik bilgiler ve tıbbi ve aromatik bitkiler olmak üzere iki kısımdan oluşan anket, Google forms üzerinden online olarak uygulanmıştır. Verilerin analizinde SPSS 24 paket programı kullanılmış, yüzdelik ve frekans hesaplamaları yapılmıştır. Araştırmaya, Türkiye genelinde 1320 sağlık çalışanı katılmış olup, katılımcıların %55’i kadın, %45’i erkektir, meslek gruplarına göre dağılımı; %18’i hemşire, %16’sı sağlık memuru, %12’si hekim, %10’u ATT, %9’u paramedik, %9’u ebe, %8’i tıbbi sekreter, %7’si eczacı, %6’sı psikolog ve %5’i diğer (sosyal çalışmacı, müdür, diş hekimi vs.) şeklindedir. Çalışma sonucuna göre; sağlık çalışanlarının %77’si Covid-19 pandemisinde tıbbi ve aromatik bitkilerin tamamen ve kısmen etkili olduğuna inandığını belirtmiş ve bunların %63’ü şifalı bitkileri kullanmıştır. Kullanılan bitkiler içinde kekik/Origanum sp. (%99), narenciye/Citrus sp. (%94) ve sarımsak/Allium sativum (%93) en yüksek düzeyde tercih edilmiştir. Tıbbi ve aromatik bitkilerin kullanımı hakkındaki bilgilerin en çok sosyal medya (%99) aracılığıyla elde edildiği görülmüştür. Katılımcıların %94’ü bitkileri aktardan temin etmiştir. Bitkiler daha çok demlenerek (%99) ve çiğ gıda (%91) şeklinde tüketilmektedir. Bu süreçte tıbbi ve aromatik bitki kullananların %63’ü Covid-19’a yakalanmadığını bildirmiştir. Sonuç olarak, Covid-19 sürecinde sağlık çalışanlarının büyük çoğunluğunun tıbbi ve aromatik bitkilerin etkisine inandığı ve şifalı bitkileri kullanmayı tercih ettikleri ortaya çıkarılmıştır. Bu çalışma modern tıp ilmi almış bireylerin tamamlayıcı tıbba olan bakışını yansıtması açısından önemli bir değere sahiptir.

At the University of Agricultural Sciences and Veterinary Medicine in Cluj-Napoca there is an old and valuable tradition regarding the knowledge and valorification of medicinal and aromatic plants. In this institution, a Medicinal Plant Resort was established (in 1904), with activity until between the two world war period, being known and appreciated in the country and abroad. Starting with 1970 (50 years ago), the scientific researches in the field of medicinal plants were resumed at USAMV Cluj-Napoca, within the Phytotechnics department of this institution. The Cluj Department of Phytotechnics has carried out multi-annual research contracts with the Fundulea Medicinal and Aromatic Plants Research Department, since its establishment (in 1975) and has maintained scientific collaborations with the Faculty of Pharmacy from Cluj-Napoca, with Plafar Cluj etc. Since 1993, when The Hop and Medicinal Plants Culture Research Center was established at the Cluj Phytotechnics Department, the investigations in the field of medicinal and aromatic plants have diversified. Under the shield of this research center, since its establishment (in 1993), the journal "Hop and Medicinal Plants" is published, which publishes scientific papers on medicinal and aromatic plants, made at USAMV Cluj-Napoca and other institutions of research in the country and abroad. This paper presents the evolution of investigations in the field of medicinal and aromatic plants within USAMV Cluj-Napoca, highlighting the studies conducted from 1970 to the present. During this period (for five decades)8are presented the doctoral theses referring to medicinal and aromatic plants defended in USAMV Cluj-Napoca. Finally, the paper includes books of medicinal and aromatic plants developed and published by teachers from Phytotechnics in Cluj.

The use of aromatic and medicinal plants in developing countries has been widely observed. The increasing human population and demands in the late decades has led to over exploitation of land in many areas thus reducing the biodiversity of medicinal plants. Aromatic and medicinal plants possess odorous volatile substances and the characteristic aroma is due to a variety of complex chemical compounds. This study was carried out in order to contribute aromatic and medicinal plants knowledge of Eastern Anatolia Region of Turkey. This investigation included twenty medicinal or aromatic plant specimens collected and photographed from Bingol provinces during the vegetation seasons 2016. With this study some medicinal and aromatic plants recorded and photographed; that might be useful for health-care programme, aromatic and medicinal plants knowledge, aromateraphy, phytoteraphy, economic agricultural policy development, alternative food programme, ethnobotany and development of drug sector.

Background Medicinal plants have long played an integral role in traditional healing systems and are crucial for meeting primary healthcare needs. This study aimed to investigate the use of medicinal plants in phytotherapy in the Ketama region of Northern Morocco. Methods Ethnobotanical data and ancestral knowledge regarding plants were collected through a field survey conducted from August 2019 to July 2021. The data were gathered using a standardized questionnaire, as well as through semistructured interviews and focus groups. Various ethnobotanical indices were applied to analyse the information collected. Results A comprehensive inventory identified a total of 81 plant species, belonging to 40 families and 65 genera. These species are used primarily to treat a variety of diseases. Notably, digestive disorders ranked first among the diseases treated, with an ICF value of 0.618. Rosmarinus officinalis L., Thymus serpyllum L., and Origanum compactum Benth exhibited the highest UV values among medicinal plants. Leaves were the most used part of the plant part (50.28%), and the decoction method was the most recommended preparation, with oral administration being the preferred mode of application of the remedy. Conclusion The Ketama region boasts a rich abundance of medicinal and aromatic plants, as evident from the quantitative analysis highlighting the significant usage of Rosmarinus officinalis L., Thymus serpyllum L., and Origanum compactum Benth. by the local population. However, further research in the form of pharmacological studies is necessary to validate their therapeutic effects.

The study of rhizospheric microbial flora for the enhancement of aroma compounds is well recognized. The rhizosphere microbes also play very important role in improving medicinal values of plants. Rhizospheric microbes affect the plant physiology by imparting several useful effects such as nitrogen fixation, nutrient uptake, and production of secondary metabolites in the medicinal and aromatic plants. Recent days there are increasing the interests in the research of the relation between rhizosphere microbes associated with medicinal plant for the improvement of quality of medicinal plants. A large variety of fungi and bacteria is recognized in the rhizosphere soil of medicinal plants that showed significant effect in secondary metabolite alteration and uptake of plant nutrient. There are reports that rhizosphere fungi not only enhanced the growth parameters in plants but also considerably modulated essential oil’s quality. This study highlighted the researches performed on active role of rhizosphere fungi on explored medicinal and aromatic plants. As the use of organic material is one of the constituents of good agricultural practices (GAPs). Therefore, this review also investigates the environmental concerns reducing the use harmful chemicals as well as recommendation for utilization of biological and organics in agriculture. Therefore, a proper understanding of role of rhizosphere mycoflora associated with the medicinal plants is essential.

Ultraviolet (UV) radiation is a part of the sunlight reaching Earth surface. The UV spectrum of solar radiation is by convention divided into three parts: UV-A: 310–400 nm, UV-B: 280–310 nm and UV-C: less than 280 nm. UV-B is the most energetic component reaching Earth surface because the stratospheric ozone layer effectively absorbs completely wavelengths below 290 nm. UV-B is an increasing threat due to increasing UV-B levels on Earth surface as a consequence of depletion of stratospheric O3. In general, the effects of atmospheric UV-B radiation are negative for biological life. Enhanced levels of UV-B radiation can indeed negatively change plant physiological processes, growth and productivity. However, while studying UV-B effects on medicinal plants, some interesting phenomena have been discovered. For example, basil plants respond positively to UV-B radiation by increasing oil yield (Chang et al. J Horticult For 1:27–31, 2009). In other studies medicinal plants show beneficial aspects in term of increase in volatile oil yield and secondary metabolite production (Kumari et al. Ecotoxicol Environ Safety 72:2013–2019, 2009c, 2010). Medicinal herbs have great market value in India and worldwide. The medicinal value of plants depends upon phenolics, antioxidants and volatile yield. Therefore further UV-B experiments increasing the levels of these compounds are needed.Here we review the effect of UV-B exposure on metabolites, volatiles, and antioxidants potential in medicinal plants. This chapter reports: (1) aspects of the global market for medicinal and aromatic plants in India in order to assist the medicinal plant industry to make informed decisions. (2) The biodiversity loss due to wild harvesting of plants, and as an alternative the cultivation strategy of medicinal plants. (3) Main medicinal plant species having rich antioxidant potential. (4) Main secondary metabolites of plant origin such as phenylpropanoids, terpenes, alkaloids, and volatile oil, and other important metabolites containing high antioxidant level used in human diet and health. (5) UV-B factors that enhance the quality of medicinal plant by increasing the content of secondary bioactive products. (6) Secondary metabolic pathways involving regulation of key enzymes, chalcone synthase, and phenylalanine ammonia lyase. Understanding of UV-B responses on secondary plant metabolites expand new opportunities for plant enriched in medicinal active compounds.

Introduction: The use of medicinal plants is still of a great interest for mankind despite the pharmaceutical industry development. This ancestral information is connected over time allowing the transmission of knowledge. The objective of this work is to conduct an ethnobotanical study on medicinal plants carried out in the region of Ain Assel, in order to evaluate, on one hand the region’s potential in medicinal plants, and on the other hand to collect all the information on traditional therapeutic uses practiced by the local population. Materials and Methods: Our survey has allowed us to identify 80 medicinal plants belonging to 46 families and 76 types, which are mostly used by the local inhabitants. The most represented family being that of the Lamiaceae with 10 species. Our results have showed that Results and discussion:The majority of remedies are prepared in the form of an infusion. The vast majority of forms of medicinal plant use are herbal teas. The large number of medicinal plants are used to treat respiratory disorders and digestive diseases. Conclusion:This study demonstrates the significance of floristic biodiversity in the region of Ain Assel. The sustainable use of this richness could be a way for the conservation of this natural heritage. In addition, sensitizing the new generation to exploit the field of phytotherapy is a way of protecting people's health.

Since thousands years back approximately around 900 BC, medicinal plants are considered as a source of many biomolecules with therapeutic potential. Herbal medicines are considered as safer, better, physiologically compatible and costeffective. The oldest evidence of medicinal and aromatic plants depicts that with the emergence of human civilization, plants have been considered as the main source to heal and cure various serious ailments. It has been proven that the secondary metabolites e.g. alkaloid, glycosides, flavonoides, steroids etc present in the medicinal plants possesses ability to prevent occurrence of some of the diseases, means medicinal plants acts as a “preventive medicine”. Medicinal plants have a paramount importance and a great interest due to its pharmaceutical, cosmetic and nutritional values. Some plants are also considered as an important source of nutrition and are known to have a variety of compounds with potential therapeutic properties. India is the principal repository of large number of medicinal and aromatic plants or we can say India is one of the rich mega-biodiversity countries of the world. Medicinal plants are “backbone” of traditional medicinal system (TMS). Crude drugs are usually dried parts of medicinal and aromatic plants (MAPs) such as roots, stems, wood, bark, seeds, fruits, flowers, leaves, rhizomes, whole plant etc. that form the essential raw material for the production of medicines in various systems of Ayurveda, Siddha, Unani, Tibatian, Tribal and Homeopathy. According to the survey of the World Health Organization (WHO), about 80% of the world population are using herbs and other traditional medicines for their primary healthcare and have established three kinds of herbal medicines: raw plant material, processed plant material, and herbal products. Now days, variety of available herbs are used throughout the world and they continue to promote good health. As the benefits from medicinal and aromatic plants are recognized, these plants will have a special role for humans in the future. The present review on medicinal and aromatic plants revealed similar combination of studies.

Every year more than 400,000 tons of medicinal and aromatic plants from approximately 3,000 species are traded internationally, according to TRAFFIC, a nonprofit watchdog group that monitors commerce in natural products. (Up to 70,000 species are used medicinally worldwide, most of them locally.) Such a growth in demand for these plants threatens natural resources, since about 80% of commercially traded species are gathered from the wild, according to the World Conservation Union (IUCN). In February 2007, several groups concerned about potential adverse effects of this rise on plant habitats announced an international standard designed to preserve nature’s medicine chest for future generations. A year later, the standard appears to be bearing fruit. The IUCN Medicinal Plant Specialist Group, IUCN Canada, the German Federal Agency for Nature Conservation, WWF Germany, and TRAFFIC proposed the standard and coordinated several rounds of international vetting in 2005 and 2006. The new International Standard for Sustainable Wild Collection of Medicinal and Aromatic Plants (ISSC-MAP) is intended to balance the needs of people whose traditions and livelihood depend on these species with the plants’ long-term survival in their native habitats. The new standard is based on six principles related to maintaining wild resources, preventing negative environmental impacts, respecting customary rights (for example, of indigenous populations), and exercising responsible management and business practices. Plant scientists also drew on earlier guidelines both for the conservation of medicinal plants and for good agricultural and collection practices. “We did not want to reinvent the wheel,” says Susanne Honnef, TRAFFIC medicinal plant officer with WWF Germany, “so the standard builds on existing frameworks.” The new standard involves all actors along the supply chain—from wild plant harvesters to sellers—in a process for determining how to sustainably conduct harvests and trade, says Honnef. The standard also outlines practices for monitoring the impact of harvests over time. Honnef says the standard will protect important natural resources. As the benefits of sustainable use become more broadly recognized, harvesters will be encouraged to protect the ecosystems that support their livelihoods. And government agencies will have tools for defining benchmarks in a trade that is often informal and that falls through the cracks between groups that manage agriculture and forestry. The standard was tested in preliminary trials undertaken in six countries. Over 6 months in 2007, for example, 2 Indian communities used the standard to gauge population health of 6 commercially traded species, says Giridhar Kinhal, special projects coordinator for Foundation for Revitalisation of Local Health Traditions, a nonprofit scientific and research organization in Bangalore. Based on that trial, says Kinhal, the communities saw improved regeneration of the studied plant populations, but also reported the need for further guidance in assimilating these outcomes into resource management. Next comes a 2-year implementation phase at sites in Asia, Africa, southeast Europe, and South America. Danna Leaman, chair of the IUCN Medicinal Plant Specialist Group and a member of the advisory group that guided the development of ISSC-MAP, says, “A concrete activity like this is a real step forward” for the IUCN, which has worked for years to engage industry in biodiversity protection. Indeed, ISSC-MAP goes even further than current guidance such as Fair Trade and Organic certification. For example, it has been up to individual inspectors to determine whether a wild collection operation meets the requirements for Organic certification. Josef Brinckmann, vice president for research with manufacturer Traditional Medicinals, says that although the wild botanicals they use qualify for Organic certification, some sites will need further work to conform with all 6 principles of the ISSC-MAP. “Many of these certified Organic wild collection sites would need a few years to make the necessary changes for conformance with the ISSC-MAP standard,” he says. Yet, Brinckmann adds, the extra work will be worthwhile if compliance with the standard can help a company demonstrate unequivocably that its operations help maintain the botanical resource. Brinckmann points to Asia and Europe as places where the standard may first have a significant impact in alleviating intense harvest pressures. “China and India are the two largest producers and exporters of medicinal plants in the world,” he notes. Southeastern European countries and Russia are also important in the world market.

Medicinal and aromatic plants (MAPs) have become a part of traditional system of medicines and have gained importance, more so in today’s world. According to the estimate of World Health Organization (WHO), about 80% of the population of developing world are making use of traditional medicines. The medicinal plants have been used for widespread purposes since ancient times in countries particularly India, China, Greece, Persia etc. In India, according to a report of AICEP, Anthropological Survey of India, 1994, it is estimated that over 7,500 species of medicinal plants are used for therapeutic uses. The major floral species which are widely used as medicinal and aromatic plants (MAPs) include Ephedra gerardiana Wall., Rauvolfia serpentina, Swertia chirata, Aconitum heterophyllum Wall. ex Royle, Rhododendron anthopogon D. Dun., Peganum harmala L. etc. The widespread use of these medicinal plants for both internal consumption and export purposes have led to their large-scale exploitation, resulting in loss of biological diversity (both at genetic and species level). Most of the medicinal plants like Rauvolfia serpentina, Gentiana kurro, Alpinia galanga, Saussurea lappa have become endangered and threatened. Overexploitation along with lack of initiatives from government bodies, absence of proper management systems and loss of traditional knowledge are some of the factors responsible for rapid biodiversity loss. Indigenous people and biodiversity complement each other and the former has played an important role in conservation of biodiversity since time immemorial. The rural communities over the period of time have gathered a pool of indigenous knowledge/know-how for cultivation of the medicinal plants and their propagation. In the meantime, the importance of local knowledge systems in conservation and preservation of the germplasm of medicinal plants have also attained global significance. In India, various programmes on medicinal plants and their conservation based on traditional knowledge are being carried out by the local people, Non Government Organizations (NGOs), Community Based Organizations (CBOs) at various grass root levels such as the districts and villages. Though an unorganized sector, the local people are playing their role in the propagation as well as conservation of the medicinal plants through the application of the concepts of herbal gardens and local “mandis” (markets). There is a need to strengthen these linkages and build upon the indigenous knowledge base of the local people through proper documentation and building of a strong database. This paper deliberates upon the importance (therapeutic, ecological and economic) of medicinal plants and threats to their biodiversity. The communication also describes the details of some of the local efforts, which are being carried out at local levels in India for conservation of medicinal plants through the use of indigenous knowledge of traditional medicines. The paper also highlights the need to integrate indigenous knowledge into national policies and strengthen the participation of the indigenous communities in order to harness maximum potential of medicinal plant biodiversity along with sustainable management of these resources.

Traditional medicine and the use of medicinal and aromatic plants in Africa are linked to social life, culture and daily activities of the African people. The celebration of life events involve the presentation and sharing of several culturally significant items such as honey, salt, Cola and other medicinal plants and their products. In this chapter, the rich and unique culture of African countries is discussed in relation to the use of medicinal and aromatic plants. As a special feature, the major medicinal and aromatic plants endemic to Western, Northern and Southern Africa are reviewed with regards to their manifold uses. The disposition of African people to traditional medicine, formulation of policies to support the growth of traditional medicine and the progress made so far are highlighted. As a result of the acceptance of African traditional medicine by a vast majority of African populace and support gained from the African Union, World Health Organization and the United Nations; African traditional medicine will in the near future be highly valued just like the Chinese traditional medicine system.

Plant growth-promoting rhizobacteria (PGPRs) are a group of naturally occurring beneficial soil bacteria that colonize with the plant root system and promote growth by triggering the production of growth-regulating substances and facilitate the plants in the uptake of essential nutrients from the surrounding environments. Similarly, arbuscular mycorrhizal (AM) fungi also enhanced the growth, water and nutrient uptake, and especially available phosphate through their specialized hyphae. In addition, PGPR and AM fungi are known to stimulate the accumulation of secondary metabolites in plants. For several years, they are commonly employed to increase the plant yield and productivity especially in agricultural practices. The medicinal and aromatic plants are gaining popularity worldwide due to high therapeutic properties with negligible toxic side effects. To fulfill the global demand and supply gap for medicinal and aromatic plants and their products, farmers are encouraged to cultivate these plants on a large scale. However, there is a need to understand and implement a better cultivation practices in order to improve the quality of medicinal and aromatic plants. In this regard, the utilization of PGPRs and AM fungi as biofertilizers instead of chemical fertilizers could be a promising approach to the development of medicinal and aromatic plants under the sustainable production system. The aim of this chapter is to describe the potentiality of PGPRs and AM fungi to improve growth and development of medicinal and aromatic plants and accumulation of secondary metabolites having high therapeutic worth and also pave a way in the development of new biotechnological products as biofertilizers.